About: In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin Goto Sponge Distinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 July 1980

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 1980 (fr) наукова стаття, опублікована в липні 1980 (uk) scientific article published on 01 July 1980 (en) artículu científicu espublizáu en xunetu de 1980 (ast) im Juli 1980 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q72081206-BE4952B6-8CA9-4178-8D1B-ABB2398ACADE
publication date	1980-07-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q72081206-E39C52D7-3180-416B-A47A-7B55F58B187E
language of work or name	English
author name string	wds:Q72081206-3710DC13-3C8E-4A3F-8DBF-AD99985BD3D3 wds:Q72081206-4A99732B-F038-479E-9556-83EC6C9653A6 wds:Q72081206-8D5E6924-0D9D-4295-831A-EB8ED1C52877 wds:Q72081206-C6B934CA-AA50-4DF7-A9AB-A973C7479906
author name string	D Taylor J Fisher K Coleman P A Hunter
rdfs:label	In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin (en) In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin (nl)
skos:prefLabel	In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin (en) In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin (nl)
name	In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin (en) In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin (nl)
title	wds:Q72081206-5886698D-E7BD-4826-83C8-9BE99E3A9E34
title	In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin (en)
page(s)	wds:Q72081206-EE13F774-4C20-4FA0-B7E0-B7AF73307DFC
page(s)	455-470
instance of	wds:Q72081206-9B43BC28-BCE6-4ED0-A6B6-FCF5D367E5DE
instance of	scholarly article
main subject	wds:Q72081206-2C18C109-721E-445B-AE6D-1E0F107D7677
main subject	amoxicillin
PubMed ID	wds:Q72081206-0E251387-9C96-4417-888C-5E0303CE1DB9
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6968746
PubMed ID	6968746
published in	wds:Q72081206-2554C502-5C27-45A0-BCB1-DAE0378D89CB
published in	Journal of Antimicrobial Chemotherapy
issue	wds:Q72081206-3418BF6E-D30C-41A2-8098-190BA45E298C
volume	wds:Q72081206-53EE4E0A-7FC6-4F78-BF03-12D4D14CA56A
issue	4
volume	6
DOI	wds:Q72081206-DFF3B0EC-584B-4BF3-A26A-6D34EC1B6052
DOI	http://dx.doi.org/10.1093/JAC/6.4.455
DOI	10.1093/JAC/6.4.455
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72081206
is cites work of	A randomised prospective controlled study of ciprofloxacin with metronidazole versus amoxicillin/clavulanic acid with metronidazole in the treatment of intra-abdominal infection In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates Ureidopenicillins and beta-lactam/beta-lactamase inhibitor combinations Clinical trial of the efficacy and safety of ticarcillin and clavulanic acid. Comparative study of amoxicillin-clavulanic acid and cephalexin in the treatment of bacteriuria during pregnancy Response of Streptococcus pyogenes to therapy with amoxicillin or amoxicillin-clavulanic acid in a mouse model of mixed infection caused by Staphylococcus aureus and Streptococcus pyogenes Kinetic and physical studies of beta-lactamase inhibition by a novel penem, BRL 42715. Beta-lactamase inhibitors from laboratory to clinic Concentrations of ticarcillin and clavulanic acid in human bone after prophylactic administration of 5.2 g of timentin Ticarcillin/clavulanic acid pharmacokinetics in children and young adults with cystic fibrosis Penicillins. A current review of their clinical pharmacology and therapeutic use. Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis Detection, distribution and inhibition of Branhamella catarrhalis beta-lactamases. Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin Amoxicillin/clavulanic acid. An update of its antibacterial activity, pharmacokinetic properties and therapeutic use. Amoxicillin-clavulanic acid in treatment of urinary tract infection due to gram-negative bacteria resistant to penicillin Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. In vitro evaluation of BRL 42715, a novel beta-lactamase inhibitor Differential effect of impaired renal function on the kinetics of clavulanic acid and amoxicillin First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study Disk diffusion susceptibility testing of ticarcillin plus clavulanic acid New formulations of amoxicillin/clavulanic acid: a pharmacokinetic and pharmacodynamic review Pharmacokinetics of ticarcillin and clavulanic acid (timentin) in relation to renal function Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid Pharmacokinetics of potassium clavulanate in combination with amoxicillin in pediatric patients Penetration of amoxicillin and potassium clavulanate into the cerebrospinal fluid of patients with inflamed meninges Twenty-one years of beating beta-lactamases In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits β-Lactamase inhibitors Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo Pharmacokinetic study of a paediatric formulation of amoxycillin and clavulanic acid in children Timentin versus piperacillin or moxalactam in the therapy of acute bacterial infections DCDB 2.0: a major update of the drug combination database Simulation of human serum pharmacokinetics of ticarcillin-clavulanic acid and ceftazidime in rabbits, and efficacy against experimental Klebsiella pneumoniae meningitis In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers USE OF AMOXICILLIN AND CLAVULANIC ACID (AUGMENTIN) IN THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS IN CHILDREN. Pharmacokinetics of amoxicillin/clavulanic acid combination after intravenous and intramuscular administration to pigeons. Effect of amoxycillin and clavulanic acid, alone and in combination, on human polymorphonuclear leukocyte function against Staphylococcus aureus. Complementary activity of mezlocillin and the combination of amoxicillin with clavulanic acid on Enterobacteriaceae. Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid. Amoxicillin sodium-potassium clavulanate: evaluation of gamma radiation induced effects by liquid chromatography on both the individual drugs and their combination Discovery of a Novel Metallo-β-Lactamase Inhibitor That Potentiates Meropenem Activity against Carbapenem-Resistant Enterobacteriaceae. High-performance liquid chromatographic assay of clavulanate in human plasma and urine by fluorimetric detection Effect of clavulanic acid on the activity of ticarcillin against Pseudomonas aeruginosa Pharmacokinetics of amoxicillin/clavulanic acid combination and of both drugs alone after intravenous administration to goats Pharmacokinetics and distribution of ticarcillin-clavulanic acid (Timentin) in experimental animals Structural approaches to pathway-specific antimicrobial agents Pharmacologic considerations in the treatment of neonatal septicemia and its complications Chemistry of newer antibiotics directed toward overcoming bacterial resistance Antibacterial activity and kill kinetics of amoxicillin-clavulanic acid combinations against Escherichia coli and Klebsiella aerogenes Bacteriological Investigations with Beta-Lactamase Inhibitors

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software